110 related articles for article (PubMed ID: 20090347)
1. Effect and risk of AEE788, a dual tyrosine kinase inhibitor, on regeneration in a rat liver resection model.
Deng M; Huang H; Dirsch O; Dahmen U
Eur Surg Res; 2010; 44(2):82-95. PubMed ID: 20090347
[TBL] [Abstract][Full Text] [Related]
2. The anti-proliferative side effects of AEE788, a tyrosine kinase inhibitor blocking both EGF- and VEGF-receptor, are liver-size-dependent after partial hepatectomy in rats.
Deng M; Huang H; Jin H; Dirsch O; Dahmen U
Invest New Drugs; 2011 Aug; 29(4):593-606. PubMed ID: 20148349
[TBL] [Abstract][Full Text] [Related]
3. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
4. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
Thaker PH; Yazici S; Nilsson MB; Yokoi K; Tsan RZ; He J; Kim SJ; Fidler IJ; Sood AK
Clin Cancer Res; 2005 Jul; 11(13):4923-33. PubMed ID: 16000591
[TBL] [Abstract][Full Text] [Related]
5. AEE788, a dual tyrosine kinase receptor inhibitor, induces endothelial cell apoptosis in human cutaneous squamous cell carcinoma xenografts in nude mice.
Park YW; Younes MN; Jasser SA; Yigitbasi OG; Zhou G; Bucana CD; Bekele BN; Myers JN
Clin Cancer Res; 2005 Mar; 11(5):1963-73. PubMed ID: 15756022
[TBL] [Abstract][Full Text] [Related]
6. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer.
Younes MN; Yazici YD; Kim S; Jasser SA; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3425-34. PubMed ID: 16740767
[TBL] [Abstract][Full Text] [Related]
7. Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice.
Yazici S; Kim SJ; Busby JE; He J; Thaker P; Yokoi K; Fan D; Fidler IJ
Prostate; 2005 Nov; 65(3):203-15. PubMed ID: 15948138
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade.
Yigitbasi OG; Younes MN; Doan D; Jasser SA; Schiff BA; Bucana CD; Bekele BN; Fidler IJ; Myers JN
Cancer Res; 2004 Nov; 64(21):7977-84. PubMed ID: 15520205
[TBL] [Abstract][Full Text] [Related]
9. The dual EGF/VEGF receptor tyrosine kinase inhibitor AEE788 inhibits growth of human hepatocellular carcinoma xenografts in nude mice.
Okamoto K; Neureiter D; Alinger B; Meissnitzer M; Sass G; Schmitz V; Di Fazio P; Wissniowski T; Gahr S; Hohenstein B; Kaufmann B; Schlösser A; Haus U; Hahn EG; Herold C; Ocker M
Int J Oncol; 2008 Oct; 33(4):733-42. PubMed ID: 18813786
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin promotes hepatic regeneration after extended liver resection in rats.
Schmeding M; Boas-Knoop S; Lippert S; Ruehl M; Somasundaram R; Dagdelen T; Neuhaus P; Neumann UP
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1125-31. PubMed ID: 18086112
[TBL] [Abstract][Full Text] [Related]
11. The effect of trimetazidine on liver regeneration after partial hepatectomy under hepatic blood inflow occlusion.
Kaya Y; Coskun T; Aral E; Erkasap N; Var A
Hepatogastroenterology; 2003; 50(51):651-5. PubMed ID: 12828053
[TBL] [Abstract][Full Text] [Related]
12. Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice.
Heinrich S; Jochum W; Graf R; Clavien PA
J Hepatol; 2006 Jul; 45(1):35-42. PubMed ID: 16698111
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM
Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907
[TBL] [Abstract][Full Text] [Related]
14. Regenerative capacities of normal and cirrhotic livers following 70% hepatectomy in rats and the effect of alpha-tocopherol on cirrhotic regeneration.
Andiran F; Ayhan A; Tanyel FC; Abbasoğlu O; Sayek I
J Surg Res; 2000 Apr; 89(2):184-8. PubMed ID: 10729248
[TBL] [Abstract][Full Text] [Related]
15. The effect of denervation on liver regeneration in partially hepatectomized rats.
Hamada T; Eguchi S; Yanaga K; Inuo H; Yamanouchi K; Kamohara Y; Okudaira S; Tajima Y; Kanematsu T
J Surg Res; 2007 Sep; 142(1):170-4. PubMed ID: 17574578
[TBL] [Abstract][Full Text] [Related]
16. Tri-iodothyronine as a stimulator of liver regeneration after partial and subtotal hepatectomy.
Bockhorn M; Frilling A; Benko T; Best J; Sheu SY; Trippler M; Schlaak JF; Broelsch CE
Eur Surg Res; 2007; 39(1):58-63. PubMed ID: 17213727
[TBL] [Abstract][Full Text] [Related]
17. Liver regeneration stimulates tumor metastases.
Harun N; Nikfarjam M; Muralidharan V; Christophi C
J Surg Res; 2007 Apr; 138(2):284-90. PubMed ID: 17254608
[TBL] [Abstract][Full Text] [Related]
18. Effect of molecular therapeutics on liver regeneration in a murine model.
Van Buren G; Yang AD; Dallas NA; Gray MJ; Lim SJ; Xia L; Fan F; Somcio R; Wu Y; Hicklin DJ; Ellis LM
J Clin Oncol; 2008 Apr; 26(11):1836-42. PubMed ID: 18398149
[TBL] [Abstract][Full Text] [Related]
19. Loss and recovery of liver regeneration in rats with fulminant hepatic failure.
Eguchi S; Lilja H; Hewitt WR; Middleton Y; Demetriou AA; Rozga J
J Surg Res; 1997 Oct; 72(2):112-22. PubMed ID: 9356231
[TBL] [Abstract][Full Text] [Related]
20. Single dose of anti-transforming growth factor-beta1 monoclonal antibody enhances liver regeneration after partial hepatectomy in biliary-obstructed rats.
Deneme MA; Ok E; Akcan A; Akyildiz H; Soyuer I; Muhtaroglu S
J Surg Res; 2006 Dec; 136(2):280-7. PubMed ID: 17046790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
